Join thousands of book lovers
Sign up to our newsletter and receive discounts and inspiration for your next reading experience.
By signing up, you agree to our Privacy Policy.You can, at any time, unsubscribe from our newsletters.
New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America
part of the The Clinics: Internal Medicine series
- Binding:
- Hardback
- Pages:
- 1440
- Published:
- May 9, 2012
- Dimensions:
- 158x233x20 mm.
- Weight:
- 506 g.
Delivery:
2-4 weeks
Expected delivery: December 26, 2024
Extended return policy to January 30, 2025
Description of New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America
Includes topics such as: Targeting IGF-1R, Tyrosine Kinase Inhibitors in Lung Cancer, Targeting mTOR, Targeting Hedgehog, Mitotic Inhibitors, Topoisomerase I Inhibitors, and New Strategies and Drugs Inhibiting Folate Pathways.
User ratings of New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America
Rate this book
In order to rate this book you must be logged in.Others also bought..
Find similar books
The book New Drugs for Malignancy, An Issue of Hematology/Oncology Clinics of North America can be found in the following categories:
You can, at any time, unsubscribe from our newsletters.
© 2024 Tales
All packages are shipped from our warehouse in the UK.
Company address: Esromgade 15, 3. - 2200 - DK
Registered company number: DK43351621
